Please login to the form below

Not currently logged in
Email:
Password:

Emas appoints Dr Neil Murray

He joins the UK-based contract research organisation as senior VP medicines development

UK-based contract research organisation Emas has appointed Dr Neil Murray as senior VP medicines development.

Dr Murray has over 22 years' experience in the pharmaceutical industry, during which time he most recently served as European medical director at Eisai Europe.

Prior to this he was head of clinical development at Ark Therapeutics and global head of pharmacovigilance at F.Hoffmann-La Roche.

In his new role at Emas Dr Murray will oversee clinical operations, regulatory affairs and drug safety.

18th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics